Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > THE SKY IS THE LIMIT ? ARE YOU RETARDED POLO?
View:
Post by losingmyshirt on Mar 31, 2022 4:20pm

THE SKY IS THE LIMIT ? ARE YOU RETARDED POLO?

AVOID POLO22 AND PTBAILEY.

COMPANY PUMPERS, PROBABLY BOB FARRELL IN DISGUISE.
Comment by PTBailey on Mar 31, 2022 5:14pm
Hello, my name is Bob Farrell and I'm  a paid pumper. LOLOLOLOL I try to avoid insults and never do so first, but how dumb can you be. Plus I have offered all you who accuse me of being a pumper opportunity to have an actual face to face conversation over Zoom and you all refuse, Why? You think because you lie, insult and hide behind your fake profile everyone else doe as well.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities